UTI Price Prediction Next Week
Analysis and Insights
News and Sentiment Analysis:
- Insider Activity: Sherrell Smith, EVP of UTI, sold 500 shares, representing 0.2% of their holdings, with no insider purchases reported in the last six months.
- Institutional Activity: 109 institutional investors increased their positions in UTI, while analysts have issued two buy ratings with a median price target of $24.0.
- ETF Performance: The Fidelity Small-Mid Multifactor ETF (FSMD), which includes UTI, has an implied analyst target price of $48.74, indicating a 15.07% upside. UTI itself has an 18.35% upside based on analyst targets.
Technical Analysis:
- RSI: UTI's RSI is 46.47, indicating a neutral position, not overbought or oversold.
- MACD: The MACD is slightly negative (-0.10), suggesting mild bearish momentum.
- Price Action: The stock closed at $26.5 on March 27, with a pre-market gain of +0.79% and a regular market loss of -0.11%.
Price Prediction and Recommendation:
Based on the analysis, UTI is expected to trade around $26.20 next week. The stock shows mixed signals, but the slight bearish technical indicators and insider selling suggest caution.
Recommendation: Sell if the stock reaches resistance levels, but consider buying if it dips to support levels.
UTI Similar Chart Price Prediction
The price of UTI is predicted to go up -13.97%, based on the high correlation periods with AMZN. The similarity of these two price pattern on the periods is 90.06%.
UTI
AMZN
Down: -13.97%Similarity: 90.06%
UTI Revenue Forecast
UTI EPS Forecast
UTI FAQs
What is UTI revenue forecast for next quarter？
UTI Analyst's Forecast
Alexander Paris
Barrington Research
Buy
2025-02-06
Price Target
$30 → $35
Upside
+18.52%
Barrington raised the firm's price target on Universal Technical to $35 from $30 and keeps an Outperform rating on the shares after the company reported Q1 results that were "significantly above expectations" and raised FY25 guidance. Noting that the stock more than doubled in 2024, the firm says it expects continued strong performance going forward, noting that Phase II of its North Star Strategy is expected to result in a five-year revenue compound annual growth rate of 10% and expanded adjusted EBITDA margins.
Mike Grondahl
Northland Capital Markets
Buy
2025-02-06
Price Target
$30 → $34
Upside
+15.14%
Eric Martinuzzi
Lake Street
Strong Buy
2025-02-06
Price Target
$22 → $31
Upside
+7.49%
